SCHEMBL4896927

SCHEMBL4896927

[O]C(=O)c1c2ccccc2cc2cc3ccccc3cc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.59
KDM4E B2RXH2 4/20 0.59
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
HPGD P15428 3/20 0.59
HSD17B10 Q99714 2/20 0.59
CYP1A2 P05177 1/20 0.59
GLA P06280 1/20 0.59
CYP2C19 P33261 1/20 0.59
GAA P10253 2/20 0.47
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
HIF1A Q16665 1/20 0.41
CYP1B1 Q16678 1/20 0.41
CYP3A4 P08684 1/20 0.38
MAPT P10636 2/20 0.38
TRPM4 Q8TD43 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
HTR2A P28223 1/20 0.36
NQO2 P16083 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4899613 0.92 ALDH1A1 (0.68) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL4896934 0.84 ALDH1A1 (0.84) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL30450396 0.81 ALDH1A1 (0.58) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL27304277 0.79 ALDH1A1 (0.53) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL22534193 0.78 ALDH1A1 (0.52) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL25189746 0.77 ALDH1A1 (0.50) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL31125071 0.75 KDM4E (0.69) ALDH1A1KDM4EMEN1KMT2AHPGD
Bicarbonate SCHEMBL10806618 0.75 ALDH1A1 (0.70) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL21164778 0.74 ALDH1A1 (0.47) ALDH1A1KDM4EMEN1KMT2AHPGD
Anthracene-9-Carboxylic Acid SCHEMBL29352186 0.74 MEN1 (1.00) ALDH1A1KDM4EMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2491915-B1 EASILY REMOVABLE CURABLE COMPOSITION FOR DENTAL USE SUN MEDICAL CO LTD (JP) 2019-07-03 EP disclosed
EP-2491915-A1 EASILY REMOVABLE CURABLE COMPOSITION FOR DENTAL USE SUN MEDICAL CO., LTD. (JP) 2012-08-29 EP disclosed
US-20120213832-A1 REMOVABLE DENTAL CURABLE COMPOSITION SUN MEDICAL CO., LTD. (JP) 2012-08-23 US disclosed
US-20080044149-A1 Polymerizable Composition TOYO INK MFG. CO., LTD. (JP) 2008-02-21 US disclosed
EP-1816152-A1 POLYMERIZABLE COMPOSITION TOYO INK MFG. CO., LTD. (JP) 2007-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120213832-A1 REMOVABLE DENTAL CURABLE COMPOSITION SMARCA5, SMARCA1, SMARCA2 ALDH1A1 1369/4885KDM4E 634/4885MEN1 2816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.